
China Soy Imports at Record as US Spat Spurs More Brazil Flows
China's soybean imports climbed to an all-time high last month as the world's biggest buyer scooped up large volumes mainly from Brazil amid concerns that its trade war with the US could boost global prices.
Soybean purchases by the Asian nation more than doubled from a month earlier to 13.92 million tons in May, China's customs data showed. Imports rose 73% in April.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNN
21 minutes ago
- CNN
US and China set to kick off fresh round of trade talks in London over intractable issues
A new round of trade negotiations between the United States and China is set to begin Monday in London as both sides try to preserve a fragile truce brokered last month. The fresh talks were announced last week after a long-anticipated phone call between US President Donald Trump and Chinese leader Xi Jinping, which appeared to ease tensions that erupted over the past month following a surprise agreement in Geneva. In May, the two sides agreed to drastically roll back tariffs on each other's goods for an initial 90-day period. The mood was upbeat. However, sentiment soured quickly over two major sticking points: China's control over so-called rare earths minerals and its access to semiconductor technology originating from the US. Beijing's exports of rare earths and their related magnets are expected to take center stage at the London meeting. But experts say Beijing is unlikely to give up its strategic grip over the essential minerals, which are needed in a wide range of electronics, vehicles and defense systems. 'China's control over rare earth supply has become a calibrated yet assertive tool for strategic influence,' Robin Xing, Morgan Stanley's chief China economist, wrote in a Monday research note. 'Its near-monopoly of the supply chain means rare earths will remain a significant bargaining chip in trade negotiations.' Since the talks in Geneva, Trump has accused Beijing of effectively blocking the export of rare earths, announcing additional chip curbs and threatening to revoke the US visas of Chinese students. The moves have provoked backlash from China, which views Washington's decisions as reneging on its trade promises. All eyes will be on whether both sides can come to a consensus in London on issues of fundamental importance. US Treasury Secretary Scott Bessent, Commerce Secretary Howard Lutnick and Trade Representative Jamieson Greer will meet a Chinese delegation led by Vice Premier He Lifeng. On Saturday, Beijing appeared to send conciliatory signals. A spokesperson for China's Commerce Ministry, which oversees the export controls, said it had 'approved a certain number of compliant applications.' 'China is willing to further enhance communication and dialogue with relevant countries regarding export controls to facilitate compliant trade,' the spokesperson said. Kevin Hassett, head of the National Economic Council at the White House, told CBS's Face the Nation on Sunday that the US side would be looking to restore the flow of rare earth minerals. 'Those exports of critical minerals have been getting released at a rate that is higher than it was, but not as high as we believe we agreed to in Geneva,' he said, adding that he is 'very comfortable' with a trade deal being made after the talks. In April, as tit-for-tat trade tension between the two countries escalated, China imposed a new licensing regime on seven rare earth minerals and several magnets, requiring exporters to seek approvals for each shipment and submit documentation to verify the intended end use of these materials. Following the trade truce negotiated in Geneva, the Trump administration expected China to lift restrictions on those minerals. But Beijing's apparent slow-walking of approvals triggered deep frustration within the White House, CNN reported last month. Rare earths are a group of 17 elements that are more abundant than gold and can be found in many countries, including the United States. But they're difficult, costly and environmentally polluting to extract and process. China controls 90% of global rare earth processing. Experts say it's possible that Beijing may seek to use its leverage over rare earths to get Washington to ease its own export controls aimed at blocking China's access to advanced US semiconductors and related technologies. The American Chamber of Commerce in China said on Friday that some Chinese suppliers of American companies have received six-month export licenses. Reuters also reported that suppliers of major American carmakers – including General Motors, Ford and Jeep-maker Stellantis – were granted temporary export licenses for a period of up to six months. While China may step up the pace of license approvals to cool the diplomatic temperature, global access to Chinese rare earth minerals will likely remain more restricted than it was before April, according to a Friday research note by Leah Fahy, a China economist and other experts at Capital Economics, a London-based consultancy. 'Beijing had become more assertive in its use of export controls as tools to protect and cement its global position in strategic sectors, even before Trump hiked China tariffs this year,' the note said. As China tackles a tariff war with the US head on, it's clear that it is continuing to cause economic pain at home. Trade data released Monday painted a gloomy picture for the country's export-reliant economy. Its overall overseas shipments rose by just 4.8% in May compared to the same month a year earlier, according to data released by China's General Administration of Customs. It was a sharp slowdown from the 8.1% recorded in April, and lower than the estimate of 5.0% export growth from a Reuters poll of economists. Its exports to the US suffered a steep decline of 34.5%. The sharp monthly fall widened from a 21% drop in April and came despite the trade truce announced on May 12 that brought American tariffs on Chinese goods down from 145% to 30%. Still, Lü Daliang, a spokesperson for the customs department, talked up China's economic strength, telling the state-run media Xinhua that China's goods trade has demonstrated 'resilience in the face of external challenges.' Meanwhile, deflationary pressures continue to stalk the world's second-largest economy, according to data released separately on Monday by the National Bureau of Statistics (NBS). In May, China's Consumer Price Index (CPI), a benchmark for measuring inflation, dropped 0.1% compared to the same month last year. Factory-gate deflation, measured by the Producer Price Index (PPI), worsened with a 3.3% decrease in May from a year earlier. Last month's drop marks the sharpest year-on-year contraction in 22 months, according to NBS data. Dong Lijuan, chief statistician at the NBS, attributed the decline in producer prices, which measures the average change in prices received by producers of goods and services, to a drop in global oil and gas prices, as well as the decrease in prices for coal and other raw materials due to low cyclical demand. The high base of last year was cited as another reason for the decline, Dong said in a statement. CNN's Hassan Tayir, Simone McCarthy, Fred He contributed reporting.
Yahoo
24 minutes ago
- Yahoo
Nutraceutical Excipients Global Strategic Business Report 2025-2030: Technological Innovations in Multi-Functional Excipients Propel Growth, Increasing Preference for Clean-Label and Natural Ingredients
The global Nutraceutical Excipients market is expected to grow from USD 5 billion in 2024 to USD 7.2 billion by 2030, at a CAGR of 6.2%. Key trends driving this market include a shift towards clean-label, organic excipients and technological advances like nanotechnology that enhance ingredient bioavailability. This report offers comprehensive insights into market trends, regional growth projections, and strategic opportunities, identifying major players such as ABF Ingredients and Cargill. Explore detailed regional analyses and future market insights to inform strategic decisions. Nutraceutical Excipients Market Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "Nutraceutical Excipients - Global Strategic Business Report" report has been added to global market for Nutraceutical Excipients was valued at US$5.0 Billion in 2024 and is projected to reach US$7.2 Billion by 2030, growing at a CAGR of 6.2% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Nutraceutical excipients are inactive ingredients used in the production of nutraceutical products such as dietary supplements, functional foods, and fortified beverages. These excipients serve a crucial role by aiding in the stabilization, preservation, and delivery of active ingredients like vitamins, minerals, and bioactive compounds. Growth in the Nutraceutical Excipients Market Is Driven by Several FactorsGrowth in the nutraceutical excipients market is driven by several factors, including innovations in excipient technology, evolving consumer preferences, and increasing regulatory scrutiny. Advances in excipient formulations, such as the development of multifunctional and bioenhancing excipients, are expanding the range of nutraceutical products available to consumers. The growing popularity of clean-label and organic products is also fueling demand for natural excipients that meet consumer expectations for purity and safety. Additionally, the rise in chronic health conditions and aging populations is increasing the need for functional and targeted nutraceuticals, further driving demand for excipients that improve the bioavailability and stability of active ingredients. Regulatory requirements for product safety and quality are pushing manufacturers to innovate, ensuring excipients meet the highest standards for efficacy and safety. How Are Innovations in Nutraceutical Excipients Shaping the Market?Technological advancements in excipient development are driving significant changes in the nutraceutical market. The demand for excipients that are organic, non-GMO, and free from allergens is on the rise, reflecting consumer preferences for clean-label products. New innovations in multifunctional excipients, which can perform multiple roles such as improving both bioavailability and stability, are gaining traction. Additionally, advancements in nanotechnology are enabling the development of excipients that enhance the solubility and absorption of poorly soluble nutraceutical ingredients. These innovations are leading to the production of more effective, faster-acting, and longer-lasting nutraceutical products, appealing to consumers who prioritize both efficacy and natural Are Consumer Preferences and Regulatory Trends Impacting Demand for Nutraceutical Excipients?The growing focus on health and wellness has spurred consumer demand for nutraceutical products that are safe, effective, and free from artificial additives. This shift is influencing the nutraceutical excipients market, as manufacturers are increasingly opting for natural, organic, and clean-label excipients that align with consumer values. Regulatory bodies are also playing a key role by setting stringent guidelines for excipient safety and quality, particularly in regions like North America and Europe. As a result, excipient manufacturers are investing in research and development to create products that comply with these regulations while offering superior functionality. Moreover, the rise of personalized nutrition is driving demand for excipients that enable the production of customized nutraceutical solutions, expanding the market's Scope Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as ABF Ingredients, Cargill, Inc., Dow, Inc., DuPont de Nemours, Inc., EGGLE Wasserburg Verwaltungs GmbH and more. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. Key Insights: Market Growth: Understand the significant growth trajectory of the Binders segment, which is expected to reach US$2.4 Billion by 2030 with a CAGR of a 7.6%. The Fillers & Diluents segment is also set to grow at 5.5% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, valued at $1.3 Billion in 2024, and China, forecasted to grow at an impressive 9.5% CAGR to reach $1.7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Segments: Functionality (Binders, Fillers & Diluents, Coating Agents, Lubricants, Disintegrants, Flavoring Agents) Form (Dry, Liquid) Tariff Impact Analysis: Key Insights for 2025What's Included in This Edition: Tariff-adjusted market forecasts by region and segment Analysis of cost and supply chain implications by sourcing and trade exposure Strategic insights into geographic shifts Buyers receive a free July 2025 update with: Finalized tariff impacts and new trade agreement effects Updated projections reflecting global sourcing and cost shifts Expanded country-specific coverage across the industry Key Attributes: Report Attribute Details No. of Pages 308 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $5 Billion Forecasted Market Value (USD) by 2030 $7.2 Billion Compound Annual Growth Rate 6.2% Regions Covered Global Key Topics Covered: MARKET OVERVIEW Influencer Market Insights Tariff Impact on Global Supply Chain Patterns Global Economic Update Nutraceutical Excipients - Global Key Competitors Percentage Market Share in 2024 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E) MARKET TRENDS & DRIVERS Rising Consumer Demand for Functional Foods and Dietary Supplements Drives Growth in Nutraceutical Excipients Market Technological Advancements in Drug Delivery Systems Propel the Adoption of Innovative Nutraceutical Excipients Increasing Preference for Clean-Label and Natural Ingredients Expands the Market for Organic Nutraceutical Excipients Growing Focus on Enhanced Bioavailability and Solubility Strengthens Demand for Advanced Excipient Formulations Rising Awareness of Preventative Healthcare and Wellness Fuels Growth in Nutraceutical Supplements, Driving Excipient Demand Technological Innovations in Multi-Functional Excipients Propel Growth in Nutraceutical Manufacturing Efficiency Increased Regulatory Scrutiny on Ingredient Safety and Quality Standards Spurs Demand for Compliant Excipients Growing Use of Probiotics and Prebiotics Expands Opportunities for Specialized Nutraceutical Excipients Consumer Trends Toward Sugar-Free and Low-Calorie Supplements Accelerate Demand for Sweetening and Flavoring Excipients Expansion of Sports Nutrition and Weight Management Products Throws the Spotlight on Performance-Enhancing Excipients Rising Popularity of Plant-Based and Vegan Nutraceuticals Strengthens the Business Case for Non-Animal Derived Excipients Growth in Elderly Population and Demand for Age-Related Supplements Propel Market Adoption of Digestive-Friendly Excipients FOCUS ON SELECT PLAYERS ABF Ingredients Cargill, Inc. Dow, Inc. DuPont de Nemours, Inc. EGGLE Wasserburg Verwaltungs GmbH Hilmar Ingredients IMCD Group BV Ingredion, Inc. Innophos Holdings, Inc. Jrs Pharma GmbH Co. KG Kerry Group plc Roquette Freres S.A. Sensient Pharmaceutical For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Nutraceutical Excipients Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

USA Today
26 minutes ago
- USA Today
US-China trade talks set for Monday in London
US-China trade talks set for Monday in London LONDON, June 9 (Reuters) - Top U.S. and Chinese officials will sit down in London on Monday for talks aimed at defusing the high-stakes trade dispute between the two superpowers that has widened in recent weeks beyond tit-for-tat tariffs to export controls over goods and components critical to global supply chains. At a still-undisclosed venue in London, the two sides will try to get back on track with a preliminary agreement struck last month in Geneva that had briefly lowered the temperature between Washington and Beijing and fostered relief among investors battered for months by U.S. President Donald Trump's cascade of tariff orders since his return to the White House in January. "The next round of trade talks between the U.S. and China will be held in the UK on Monday," a UK government spokesperson said on Sunday. "We are a nation that champions free trade and have always been clear that a trade war is in nobody's interests, so we welcome these talks." More: US and China agree to lower tariff levels, 90-day pause Gathering there will be a U.S. delegation led by Treasury Secretary Scott Bessent, Commerce Secretary Howard Lutnick and U.S. Trade Representative Jamieson Greer, and a Chinese contingent helmed by Vice Premier He Lifeng. The second-round of meetings comes four days after Trump and Chinese leader Xi Jinping spoke by phone, their first direct interaction since Trump's January 20 inauguration. During the more than one-hour-long call, Xi told Trump to back down from trade measures that roiled the global economy and warned him against threatening steps on Taiwan, according to a Chinese government summary. But Trump said on social media the talks focused primarily on trade led to "a very positive conclusion," setting the stage for Monday's meeting in London. More: Britain agrees trade and defense reset with European Union The next day, Trump said Xi had agreed to resume shipments to the U.S. of rare earths minerals and magnets. China's decision in April to suspend exports of a wide range of critical minerals and magnets upended the supply chains central to automakers, aerospace manufacturers, semiconductor companies and military contractors around the world. That had become a particular pain point for the U.S. in the weeks after the two sides had struck a preliminary rapprochement in talks held in Switzerland. There, both had agreed to reduce steep import taxes on each other's goods that had had the effect of erecting a trade embargo between the world's No. 1 and 2 economies, but U.S. officials in recent weeks accused China of slow-walking on its commitments, particularly around rare earths shipments. "We want China and the United States to continue moving forward with the agreement that was struck in Geneva," White House spokeswoman Karoline Leavitt told the Fox News program "Sunday Morning Futures' on Sunday. "The administration has been monitoring China's compliance with the deal, and we hope that this will move forward to have more comprehensive trade talks." The inclusion at the London talks of Lutnick, whose agency oversees export controls for the U.S., is one indication of how central the issue has become for both sides. Lutnick did not attend the Geneva talks, at which the countries struck a 90-day deal to roll back some of the triple-digit tariffs they had placed on each other since Trump's inauguration. That preliminary deal sparked a global relief rally in stock markets, and U.S. indexes that had been in or near bear market levels have recouped the lion's share of their losses. The S&P 500 Index .SPX, which at its lowest point in early April was down nearly 18% after Trump unveiled his sweeping "Liberation Day" tariffs on goods from across the globe, is now only about 2% below its record high from mid-February. The final third of that rally followed the U.S.-China truce struck in Geneva. Still, that temporary deal did not address broader concerns that strain the bilateral relationship, from the illicit fentanyl trade to the status of democratically governed Taiwan and U.S. complaints about China's state-dominated, export-driven economic model. While the UK government will provide a venue for Monday's discussions, it will not be party to them but will have separate talks later in the week with the Chinese delegation. (Reporting by Trevor Hunnicutt in Washington, Nathan Layne in Connecticut, Brenda Goh in Washington and Kate Holton in London; Writing by Dan Burns; Editing by Chris Reese)